drugset / Trial / NCT02813486
Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to evaluate safety of GC3111 and to describe immunogenicity of a single dose of GC3111 versus Boostrix® vaccine among healthy adults in 19 to \<65 years of age.
Timeline
- Start
- 2016-06
- Primary completion
- 2016-11
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Boostrix | Vaccine | 0.5 ml | Intramuscular |
| Subject | GC3111 | Vaccine | 0.5 ml | Intramuscular |